Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database.

UST was found to have the highest persistence rate among all BTs for psoriasis treatment in Japan. The 12-month medical costs after BT initiation in the persistent patient group may not have increased as much as in the non-persistent patient group for some medications.